Astellas Pharma Stock Price on November 18, 2024

Astellas Pharma Valuation on November 18, 2024

Astellas Pharma Trading Date Momentum on November 18, 2024

On November 19 2024 Astellas Pharma was traded for  9.75  at the closing time. The highest daily price throughout the period was 9.75  and the lowest price was  9.75 . The daily volume was 4.7 K. The net trading volume on 11/19/2024 did not affect price variability. The overall trading delta to current closing price is 8.72% .

Astellas Pharma Fundamentals Correlations and Trends

By evaluating Astellas Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Astellas Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Astellas financial account trend analysis is a perfect complement when working with valuation or volatility modules.

Astellas Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Astellas is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Astellas Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Astellas Pharma stock prices may prove useful in developing a viable investing in Astellas Pharma

Astellas Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how Astellas Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astellas Pharma shares will generate the highest return on investment. By undertsting and applying Astellas Pharma pink sheet market strength indicators, traders can identify Astellas Pharma entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for Astellas Pharma's price direction in advance. Along with the technical and fundamental analysis of Astellas Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Astellas to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.